Skip to main content
EJNMMI Research

Table 1 Mean bodyweight at baseline, week 16 and corresponding differences with confidence intervals

From: Toxicity of a combined therapy using the mTOR-inhibitor everolimus and PRRT with [177Lu]Lu-DOTA-TATE in Lewis rats

Bodyweight (g)

Baseline

Week 16

Difference (%)

Placebo

204.0 ± 7.5

230.2 ± 10.5

12.8 ± 2.7

Everolimus

204.7 ± 5.2

222.9 ± 5.6

9.0 ± 2.9

Placebo + [177Lu]Lu-DOTA-TATE

208.4 ± 3.8

230.5 ± 10.1

10.6 ± 4.5

Everolimus + [177Lu]Lu-DOTA-TATE

208.4 ± 4.5

221.1 ± 10.8

6.0 ± 4.0

Back to article page